Back to funds
View filing
M28 Capital Management LP
hedge fundUpdated 28 days agoManaged by M28 Capital Management Lp • Latest filing Q2 2026
Portfolio value
$47.2M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
17.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $88.4M |
| Q2 2023 | $75.7M |
| Q3 2023 | $87.2M |
| Q4 2023 | $120.7M |
| Q1 2024 | $135.3M |
| Q2 2024 | $77.1M |
| Q3 2024 | $91M |
| Q4 2024 | $101.9M |
| Q1 2025 | $73M |
| Q2 2025 | $58.6M |
| Q3 2025 | $68M |
| Q4 2025 | $137.6M |
| Q1 2026 | $53.8M |
| Q2 2026 | $47.2M |
Top holdings
9 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | W WVE WAVE LIFE SCIENCES LTD | $26.7M | 4.59M | 56.53% | — |
| 2 | I IVVD INVIVYD INC | $8.1M | 9.25M | 17.11% | — |
| 3 | T TGTX TG THERAPEUTICS INC | $4.9M | 88.4K | 10.29% | — |
| 4 | A ARWR ARROWHEAD PHARMACEUTICALS IN | $3M | 36.9K | 6.37% | — |
| 5 | G GUTS FRACTYL HEALTH INC | $1.5M | 1.86M | 3.13% | — |
| 6 | P PRQR PROQR THRAPEUTICS N V | $1.1M | 599.8K | 2.37% | — |
| 7 | S SLNCF SILENCE THERAPEUTICS PLC | $1.1M | 101.2K | 2.36% | — |
| 8 | R RCL ROCKET PHARMACEUTICALS INC | $721K | 210.9K | 1.53% | — |
| 9 | C CRIS CURIS INC | $149K | 284.9K | 0.32% | — |